Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”, a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.

 Key Responsibilities

 

Strategic Portfolio Leadership: Own the 3-year strategic MEG plan for Oncology (solid tumor and hematology), the largest portfolio in MEG, comprising ~60% of the overall Book of Work, setting direction, priorities, and trade-offs across the full portfolio of studies in partnership with the worldwide TA (WWTA) leadership.

Integrated Evidence Planning: Set the strategic framework for, and provide executive oversight of the IEPs for Oncology assets/indications across both solid tumor and hematology, ensuring alignment with unmet medical needs and enterprise business priorities, in partnership with WWTA teams, HEOR, GDD and other senior internal stakeholders.

Enterprise Portfolio Ownership: Hold ultimate accountability for the strategic direction, prioritization, and governance of the Oncology MEG book of work (Medical Affairs sponsored studies, clinical research collaborations, investigator-sponsored studies and Real World Evidence studies), ensuring the portfolio remains on strategy, appropriately resourced, and delivering enterprise-level impact.

Matrix and Executive Leadership: Serve as a senior matrix partner to the Global TA Head, Global Medical and International Medical leadership teams. Set direction for Medical governance through the TAG forum and provide executive sponsorship for MEG leads leading EGWG meetings.

Innovation and Data-Driven Strategy: Champion a culture of innovation across the portfolio, driving enterprise-level initiatives to advance evidence generation approaches and using digital and AI tools, data analytics and business acumen to define the value drivers that shape portfolio-level, data-driven decisions.

Portfolio Governance and Oversight: Provide senior scientific and strategic oversight for the full portfolio of studies within remit, holding the organization accountable for rigor, timeliness, and quality, while maintaining overall fiscal stewardship and a balanced budget for the MEG Book of Work (BOW) at the portfolio level.

Chair the Review Committees for final protocols, amendments, and budgets for studies under remit, exercising executive judgment on portfolio-level trade-offs.

Serve as the senior subject matter expert and executive voice on the Oncology book of work, providing strategic updates to senior leadership and key stakeholders across the enterprise.

Organizational Leadership: Lead, develop, and set strategic direction for a large team of 25+ professionals, including MEG Leads, Clinical Scientists, Clinical Trial Physicians and project managers, building organizational capability and empowering leaders within the team to drive execution, rather than managing day-to-day operational detail.

External and Executive Engagement: Serve as a trusted senior expert and enterprise representative in engagements with investigators, external stakeholders, and cross-functional executive teams, shaping scientific rationale, strategic impact, and portfolio-level decisions on execution, budget, and data readouts.

Qualifications & Experience

Advanced scientific degree (e.g. Pharm.D., MD, PhD) with 15+ years of experience; 5+ years clinical trial expertise with a mix of development/clinical and medical with an emphasis on conduct/execution of trials, plus demonstrated experience operating at a strategic, portfolio-wide level.

Formal specialization in areas associated with the current Oncology portfolio (solid tumor and/or hematology) and/or professional experience with assets in this space is preferred.

Cross-Functional Alignment & Influence: Proven ability to align across diverse senior teams and influence executive stakeholders toward shared strategic success.

Outcome-Driven Execution: Demonstrated capability to set strategic direction that drives initiatives beyond effectiveness, ensuring measurable enterprise-level impact and results.

People Management Excellence: Strong track record of building and developing organizational talent and future leaders, with a focus on performance, engagement, and growth at scale.

Entrepreneurial Mindset: Ability to anticipate market dynamics and identify strategic opportunities to accelerate pipeline development across a major portfolio.

Strong executive presence with excellent analytical skills, strategic evidence interpretation and contextualization, and the ability to influence effectively across senior cross-functional teams including GDD, commercialization, regulatory, HEOR and Access.

HQ based position with international/domestic travel requirement approximately 25%

If you come across a role that intrigues you but doesn’t perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career.

Uniquely Interesting Work, Life-changing Careers

With a single vision as inspiring as “Transforming patients’ lives through science™ ”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to apply our individual talents and unique perspectives in an inclusive culture, promoting diversity in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.

Compensation Overview:

$326,660 - $395,829

The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully – carefully considering the nature of the role, required skills, work location, schedule and the knowledge and experience you bring. Final compensation is guided by pay equity principles and applicable employment laws. Compensation programs are reviewed on an ongoing basis and may be adjusted over time to reflect evolving market factors, and individual, team or Company performance.

Benefits:

Subject to the terms and conditions of the applicable plans then in effect, you may be eligible to participate in our comprehensive benefit plans – including wellbeing support, retirement and financial protection benefits, and insurance offerings (medical, dental, vision, life and disability).

U.S.-based exempt employees are eligible for Flexible Time Off (FTO), which provides paid time off without a set accrual limit, subject to manager approval, along with 11 paid company holidays each year.

Non-exempt employees, RayzeBio employees, and employees located in Puerto Rico receive 160 hours of paid vacation annually for new hires (subject to manager approval), 11 paid company holidays, and 3 optional holidays.

Depending on eligibility, employees may also have access to additional time-off benefits, including paid sick leave, up to two paid volunteer days per year, summer hours flexibility, and leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs. Eligible employees also enjoy an annual Global Shutdown between Christmas Day and New Year's Day.

U.S.-based job seekers can explore full benefit offerings at https://careers.bms.com/benefits

How We Work

Where you work matters – because collaboration, innovation and patient impact happen in many settings. Our roles are structured across four work models: site-essential, site-by-design, field-based and remote-by-design. The model assigned to this role is based on its core responsibilities. Learn more at https://careers.bms.com/ways-of-working.

Supporting People with Disabilities

BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations/adjustments and ongoing support in their roles. Applicants can request a reasonable workplace accommodation/adjustment prior to accepting a job offer. If you require reasonable accommodations/adjustments in completing this application, or in any part of the recruitment process, direct your inquiries to  adastaffingsupport@bms.com . Visit  careers.bms.com/eeo-accessibility  to access our complete Equal Employment Opportunity statement.

Candidate Rights

BMS will consider qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.

For roles based in Los Angeles County only:  If you live in or expect to work from Los Angeles County if hired for this position, please visit this page for important additional information:  https://careers.bms.com/california-residents/

For roles based in Washington State only: If you live in or expect to work from Washington State if hired for this position, please visit this page for important information about the Washington Fair Chance Act.

Data Protection

We will never request payments, financial information, or social security numbers during our application or recruitment process. Learn more about protecting yourself at  https://careers.bms.com/fraud-protection .

Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.

If this posting is missing required information required by local law or incorrect, contact BMS at  TAEnablement@bms.com with the Job Title and Requisition number. Do not send application-related inquiries to this email. To check your application status, please login to your Candidate Home Account.

R1607115 : Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances